| Literature DB >> 35566880 |
Mat Junoh Azuraini1, Sevakumaran Vigneswari2, Kai-Hee Huong1,3,4, Wan M Khairul2, Abdul Khalil H P S5, Seeram Ramakrishna6, Al-Ashraf Abdullah Amirul1,3,7.
Abstract
In this study, we described the preparation of sponge-like porous scaffolds that are feasible for medical applications. A porous structure provides a good microenvironment for cell attachment and proliferation. In this study, a biocompatible PHA, poly(3-hydroxybutyrate-co-4-hydroxybutyrate) was blended with gelatine to improve the copolymer's hydrophilicity, while structural porosity was introduced into the scaffold via a combination of solvent casting and freeze-drying techniques. Scanning electron microscopy results revealed that the blended scaffolds exhibited higher porosity when the 4HB compositions of P(3HB-co-4HB) ranged from 27 mol% to 50 mol%, but porosity decreased with a high 4HB monomer composition of 82 mol%. The pore size, water absorption capacity, and cell proliferation assay results showed significant improvement after the final weight of blend scaffolds was reduced by half from the initial 0.79 g to 0.4 g. The pore size of 0.79g-(P27mol%G10) increased three-fold while the water absorption capacity of 0.4g-(P50mol%G10) increased to 325%. Meanwhile, the cell proliferation and attachment of 0.4g-(P50mol%G10) and 0.4g-(P82mol%G7.5) increased as compared to the initial seeding number. Based on the overall data obtained, we can conclude that the introduction of a small amount of gelatine into P(3HB-co-4HB) improved the physical and biological properties of blend scaffolds, and the 0.4g-(P50mol%G10) shows great potential for medical applications considering its unique structure and properties.Entities:
Keywords: P(3HB-co-4HB); blend scaffolds; freeze-drying; geazlatine; porous; solvent casting
Year: 2022 PMID: 35566880 PMCID: PMC9104733 DOI: 10.3390/polym14091710
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
List of common examples materials incorporated with gelatine to improve surface functionalisation.
|
Biopolymer/ | Types of Cells | Applications | References |
|---|---|---|---|
| Poly(lactic- | Human Mesenchymal Stem (hMSC) | Myocardial tissue engineering | [ |
| Poly(lactic- | Human umbilical vein | Soft tissue engineering applications | [ |
| Poly(l-lactic acid) (PLLA) | Neonatal human dermal | Skin tissue engineering | [ |
| P(3HB- | Human Bone Marrow | Scaffold for tissue engineering | [ |
| Polycaprolactone (PCL), nanohydroxyapatite (nHAp). | Human osteoblast cell line | Bone tissue engineering | [ |
| Poly(3-hydroxybutyrate- | 3T3 fibroblasts, | Diabetic wound healing | [ |
| Gellan gum | Human dermal fibroblast (HDF), | Burn wound therapy | [ |
| Poly(3-hydroxybutyrate- | Schwan cells (RSC96) | Drug delivery applications. | [ |
| Pullulan | Osteoblast precursor | Bio-hydrogel for biomedical applications | [ |
| Gellan gum | Human-induced pluripotent stem cells (hiPSC)-derived cardiomycytes | Cardiac tissue engineering | [ |
Figure 1Schematic representation of the fabrication of P(3HB-co-4HB)/gelatine blend scaffolds which was prepared by solvent casting the mixture of fish gelatine and P(3HB-co-4HB) followed by freeze drying the scaffolds.
Figure 2Surface morphology of P(3HB-co-4HB)/gelatine blend scaffolds with final weight of (a) 0.79g-(P27mol%G10); (b) 0.4g-(P27mol%G10); (c) 0.79g-(P50mol%G10); (d) 0.4g-(P50mol%G10); (e) 0.79g-(P82mol%G7.5); (f) 0.4g-(P82mol%G7.5).
The pore size and porosity of P(3HB-co-4HB)/gelatine blend scaffolds at different final weight of blend scaffolds.
| Scaffold formulation | Pore size (µm) | Porosity (%) |
|---|---|---|
| 0.79g-(P27mol%G10) | 21 ± 4 | 20 ± 0 |
| 0.79g-(P50mol%G10) | 14 ± 3 | 21 ± 3 |
| 0.79g-(P82mol%G7.5) | 45 ± 16 | 5 ± 0 |
| 0.4g-(P27mol%G10) | 64 ± 21 | 40 ± 1 |
| 0.4g-(P50mol%G10) | 49 ± 9 | 40 ± 0 |
| 0.4g-(P82mol%G7.5) | 17 ± 7 | 5 ± 3 |
Figure 3FTIR spectra of (a) P(3HB-co-4HB), (b) Gelatine (c) P(3HB-co-4HB)/gelatine blend scaffolds. Arrow 1, 2 and 3, indicate the ester group, amide I and amide II, respectively.
The thickness and solubility of P(3HB-co-4HB)/gelatine blend scaffolds.
| Scaffolds | Thickness (mm) | Solubility (%) | Retain (%) |
|---|---|---|---|
| 0.79g-(P27mol%G10) | 1.81 ± 0.064 | 12 ± 2 | 88 ± 2 |
| 0.79g-(P50mol%G10) | 0.50 ± 0.015 | 3 ± 0 | 97 ± 0 |
| 0.79g-(P82mol%G7.5) | 0.44 ± 0.014 | 2 ± 1 | 98 ± 1 |
| 0.4g-(P27mol%G10) | 0.96 ± 0.014 | 16 ± 3 | 84 ± 3 |
| 0.4g-(P50mol%G10) | 0.32 ± 0.012 | 12 ± 1 | 88 ± 1 |
| 0.4g-(P82mol%G7.5) | 0.22 ± 0.015 | 10 ± 1 | 90 ± 1 |
Values are means ± SD of three replicates. Means in the same column that are labeled with different alphabets are significantly.different (Tukey’s HSD test, p < 0.05).
Figure 4Water absorption capacity varying blend scaffolds.
Figure 5The cell viability of L929 cells of the various P(3HB-co-4HB)/gelatine blend scaffolds on day three for different contents of gelatin with final weights of 0.79 g and 0.4 g. Values are the mean of three replicates. Negative controls are P(3HB-co-4HB) without the incorporation of gelatine. Mean data accompanied by * asterisks represent a statistically significant difference within the group (Tukey’s HSD test, * p < 0.05).
Figure 6AFM topographic image of (a) 0.4g-(P27mo%), (b) 0.4g-(P27mol%G10); (c) 0.4g-(P50mol%), (d) 0.4g-(P50mol%G10); (e) 0.4g-(P82mo%) (f) 0.4g-(P82mol%G7.5).